Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

Background Mpox emerged as a significant global public health concern during the 2022–2023 outbreak, impacting populations in ...

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...

The city of Milwaukee Health Department said "failure to act swiftly ... will place children at serious risk." ...

Dr. Michelle Bischoff is an Intermountain Health cardiologist at Intermountain McKay-Dee Hospital in Ogden. February is ...

In a new clinical study, scientists from the German Federal Institute for Risk Assessment (BfR) have traced the path and ...

About 5% of people who catch COVID have long-lasting symptoms. In these people, loss of smell, dizziness, fatigue and other hallmark COVID symptoms ...

The trend and outlook of Asia-Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia-Pacific nanocellulose market in ...

The county’s internal auditor reported that in a sampling of contracts and expenditures paid for with American Rescue Plan ...

Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...

A new study using Mendelian randomization suggests that higher copper levels may increase fibromyalgia risk, while iron may ...